Back to calendar
Braveheart Bio, Inc. (BRVE) Earnings
BRVE reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $1.66
Actual EPS: $-0.33
Company overview
Market Cap$1.9B
PriceUSD 25.50
52-week high32.00
52-week low24.30
SectorHealth Technology
IndustryPharmaceuticals: Major